<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03602677</url>
  </required_header>
  <id_info>
    <org_study_id>ICG-COLORAL</org_study_id>
    <nct_id>NCT03602677</nct_id>
  </id_info>
  <brief_title>Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage</brief_title>
  <acronym>ICG-COLORAL</acronym>
  <official_title>Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Central Finland Hospital District</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital District of Helsinki and Uusimaa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Päijänne Tavastia Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seinäjoki Central Hospital, Seinäjoki, Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oulu University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, controlled, parallel, multicenter trial to determine the difference in
      post-operative anastomotic leakages in colorectal surgery, where anastomosis perfusion is
      evaluated using indocyanine green fluorescence imaging as an addition to standard surgical
      practice compared to surgical practice alone.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 24, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anastomosis leakage rate</measure>
    <time_frame>0 to 90 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severity of anastomosis leakage</measure>
    <time_frame>0 to 90 days</time_frame>
    <description>Grade A-C according to International Study Group of Rectal Cancer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Timing of anastomosis leakage</measure>
    <time_frame>0 to 90 days</time_frame>
    <description>Days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deep surgical site infections</measure>
    <time_frame>0 to 90 days</time_frame>
    <description>Yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital readmission rate</measure>
    <time_frame>0 to 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reoperation rate</measure>
    <time_frame>0 to 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30- and 90-day complications according to Clavien-Dindo Classification</measure>
    <time_frame>0 to 90 days</time_frame>
    <description>Clavien-Dindo Score from Grade 0 (no complications) to Grade V (Death of a patient). Five grades and additionally Grade III and IV will be divided to a and b.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operation time</measure>
    <time_frame>0-600 minutes</time_frame>
    <description>Time from the start of the operation until the surgeon has ended the operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>0-365 days</time_frame>
    <description>Day of the operation is considered the day 0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30- and 90-day mortality</measure>
    <time_frame>0 to 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first bowel movement</measure>
    <time_frame>0-30 days</time_frame>
    <description>Postoperative day when the first bowel movement occurs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first flatus</measure>
    <time_frame>0-30 days</time_frame>
    <description>Postoperative day when the first flatus occurs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital costs</measure>
    <time_frame>0 to 90 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1062</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Colorectal Neoplasms</condition>
  <condition>Gastrointestinal Cancer</condition>
  <condition>Gastrointestinal Neoplasms</condition>
  <condition>Diverticulosis, Colonic</condition>
  <condition>Gastrointestinal Disease</condition>
  <arm_group>
    <arm_group_label>ICG fluorescence imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Colorectal surgery and anastomosis will be performed according to standard practice with the addition of intraoperative indocyanine green fluorescence imaging.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard procedure</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard colorectal surgery and anastomosis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ICG fluorescence imaging</intervention_name>
    <description>The use of indocyanine green fluorescence imaging as an addition to standard surgical procedure.</description>
    <arm_group_label>ICG fluorescence imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All consenting patients in the catchment area of participating hospitals who undergo
             elective colorectal surgery with planned primary anastomosis are eligible for this
             study.

          -  Of rectal cancer patients only those with pathology in the proximal third will be
             included in the study (defined by area proximal from peritoneal fold).

        Exclusion Criteria:

          -  Emergent patients

          -  Patients with proven diverticular abscess and colonic fistulas are excluded

          -  Patients with planned open surgery are excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jyrki Kössi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Päijänne Tavastia Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Olli Helminen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oulu University Hospital, Oulu, Finland and Central Finland Central Hospital, Jyväskylä, Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Heikki Huhta, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oulu University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juha Rinne, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Päijänne Tavastia Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matti Kairaluoma, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Finland Central Hospital, Jyväskylä, Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tero Rautio, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oulu University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jyrki Kössi, MD, PhD</last_name>
    <phone>+358381911</phone>
    <email>jyrki.kossi@phhyky.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Olli Helminen, MD, PhD</last_name>
    <phone>+358142691811</phone>
    <email>olli.helminen@oulu.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Central Finland Central Hospital</name>
      <address>
        <city>Jyväskylä</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olli Helminen, MD, PhD</last_name>
      <email>olli.helminen@ksshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Päijät Häme Central Hospital</name>
      <address>
        <city>Lahti</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jyrki Kössi, MD, PhD</last_name>
      <email>jyrki.kossi@phhyky.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>March 25, 2018</study_first_submitted>
  <study_first_submitted_qc>July 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2018</study_first_posted>
  <last_update_submitted>September 26, 2018</last_update_submitted>
  <last_update_submitted_qc>September 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oulu University Hospital</investigator_affiliation>
    <investigator_full_name>Olli Helminen</investigator_full_name>
    <investigator_title>MD, PhD, Resident, Surgery</investigator_title>
  </responsible_party>
  <keyword>Colorectal surgery</keyword>
  <keyword>Anastomosis</keyword>
  <keyword>Anastomosis leak</keyword>
  <keyword>Fluorescence imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diverticulum</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Gastrointestinal Neoplasms</mesh_term>
    <mesh_term>Digestive System Neoplasms</mesh_term>
    <mesh_term>Gastrointestinal Diseases</mesh_term>
    <mesh_term>Diverticulosis, Colonic</mesh_term>
    <mesh_term>Anastomotic Leak</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Digestive System Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 15, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/77/NCT03602677/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

